Minapharm gets up to $16.5 million CEPI funding to advance Bundibugyo Ebola vaccine
Cronus Pharma unveils FDA-approved generic Robenacoxib injection for veterinary use
Bausch + Lomb advances two first-in-class eye treatments to new trials
Abbott wins FDA authorization for first dual glucose-ketone sensor
Piramal Pharma reports 22.6% reduction in Scope 1 and Scope 2 greenhouse gas emissions
Jagat Pharma expands nutraceutical portfolio with six new wellness products
Zepbound use linked to lower healthcare costs in older adults: Lilly study
COSCON 2026 to bring together 1,250+ aesthetic medicine experts in New Delhi
Nippon Soda hits milestone in MabGenesis deal for feline inflammatory disease treatment
Thermo Fisher launches Orbitrap Mass Spectrometers
The company currently holds 96% of Bharat Serums and Vaccines directly, while the remaining 4% is held through its wholly owned subsidiary, Appian Properties
Subscribe To Our Newsletter & Stay Updated
Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants
Implementing a digital transformation in chemical operations to maximize profitability
The complexity of compliance
The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation
The guiding role of fluidized and spouted bed technologies in particle building processes
